Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02537418 |
|---|---|
| Brief Title: | Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens |
| First Submitted : | August 27, 2015 |
| First Submitted that Met QC Criteria : | August 31, 2015 |
| First Posted : | September 1, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | February 9, 2024 |
| Last Update Posted : | February 12, 2024 |